Ren; Qingyun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ren; Qingyun.The latest application filed is for "a teixobactin analogue and use thereof".

Company Profile

16.26.30

Ren; Qingyun - Dongguan CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused tetracyclic compounds and uses thereof in medicine Grant 11,447,498 - Huang , et al. September 20, 2	2022-09-20
A Teixobactin Analogue And Use Thereof App 20220273760 - REN; Qingyun ; et al.	2022-09-01
Dihydropyrimidine Compound And Application Thereof As Drug App 20220194951 - REN; Qingyun ; et al.	2022-06-23
Dihydropyrimidine compounds and uses thereof in medicine Grant 11,261,190 - Liu , et al. March 1, 2	2022-03-01
Fused Tetracyclic Compounds And Uses Thereof In Medicine App 20220041614 - HUANG; Jianzhou ; et al.	2022-02-10
Inhibitors of influenza virus replication, application methods and uses thereof Grant 11,225,477 - Zhang , et al. January 18, 2	2022-01-18
Dihydropyrimidine compounds and uses thereof in medicine Grant 11,142,527 - Ren , et al. October 12, 2	2021-10-12
Influenza virus replication inhibitor and use thereof Grant 11,104,689 - Tang , et al. August 31, 2	2021-08-31
Inhibitors of influenza virus replication and uses thereof Grant 11,098,042 - Ren , et al. August 24, 2	2021-08-24
Fused Tricyclic Compounds And Uses Thereof In Medicine App 20210236493 - HUANG; Jianzhou ; et al.	2021-08-05
Inhibitors of influenza virus replication and uses thereof Grant 10,987,354 - Tang , et al. April 27, 2	2021-04-27
Fused tricyclic compounds and uses thereof in medicine Grant 10,966,970 - Liu , et al. April 6, 2	2021-04-06
Inhibitors of influenza virus replication and uses thereof Grant 10,927,118 - Tang , et al. February 23, 2	2021-02-23
Inhibitors Of Influenza Virus Replication And Uses Thereof App 20200339564 - REN; Qingyun ; et al.	2020-10-29
Inhibitors Of Influenza Virus Replication, Application Methods And Uses Thereof App 20200299294 - ZHANG; Yingjun ; et al.	2020-09-24
Influenza Virus Replication Inhibitor And Use Thereof App 20200283454 - TANG; Changhua ; et al.	2020-09-10
Dihydropyrimidine Compounds And Uses Thereof In Medicine App 20200283445 - LIU; Xinchang ; et al.	2020-09-10
Inhibitors of influenza virus replication, application methods and uses thereof Grant 10,717,732 - Zhang , et al.	2020-07-21
Inhibitors of influenza virus replication, application methods and uses thereof Grant 10,647,693 - Tang , et al.	2020-05-12
Fused Tricyclic Compounds And Uses Thereof In Medicine App 20200113879 - LIU; Xinchang ; et al.	2020-04-16
Dihydropyrimidine Compounds And Uses Thereof In Medicine App 20200115381 - REN; Qingyun ; et al.	2020-04-16
Inhibitors Of Influenza Virus Replication And Uses Thereof App 20200085822 - TANG; Changhua ; et al.	2020-03-19
Inhibitors Of Influenza Virus Replication And Uses Thereof App 20200010472 - TANG; Changhua ; et al.	2020-01-09
Inhibitors of influenza virus replication, application methods and uses thereof Grant 10,501,444 - Ren , et al. Dec	2019-12-10
Inhibitors Of Influenza Virus Replication, Application Methods And Uses Thereof App 20190194159 - TANG; Changhua ; et al.	2019-06-27
Inhibitors Of Influenza Virus Replication, Application Methods And Uses Thereof App 20190185456 - REN; Qingyun ; et al.	2019-06-20
Inhibitors Of Influenza Virus Replication, Application Methods And Uses Thereof App 20180346463 - ZHANG; Yingjun ; et al.	2018-12-06
Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals Grant 10,098,889 - Ren , et al. October 16, 2	2018-10-16
Complexes And Salts Of Dihydropyrimidine Derivatives And Their Application In Pharmaceuticals App 20180263991 - Ren; Qingyun ; et al.	2018-09-20
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof Grant 9,802,949 - Zhang , et al. October 31, 2	2017-10-31
Dihydropyrimidine compounds and their application in pharmaceuticals Grant 9,771,358 - Zhang , et al. September 26, 2	2017-09-26
Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof Grant 9,738,629 - Zhang , et al. August 22, 2	2017-08-22
Processes for preparing dihydropyrimidine derivatives and intermediates thereof Grant 9,643,962 - Ren , et al. May 9, 2	2017-05-09
Processes for preparing dihydropyrimidine derivatives and intermediates thereof Grant 9,617,252 - Liu , et al. April 11, 2	2017-04-11
Processes for preparing dihydropyrimidine derivatives and intermediates thereof Grant 9,573,941 - Ren , et al. February 21, 2	2017-02-21
Bridged Ring Compounds As Hepatitis C Virus Inhibitors, Pharmaceutical Compositions And Uses Thereof App 20170044140 - ZHANG; Yingjun ; et al.	2017-02-16
Dihydropyrimidine Compounds And Their Application In Pharmaceuticals App 20160347746 - Zhang; Yingjun ; et al.	2016-12-01
Dihydropyrimidine compounds and their application in pharmaceuticals Grant 9,498,479 - Zhang , et al. November 22, 2	2016-11-22
Processes For Preparing Dihydropyrimidine Derivatives And Intermediates Thereof App 20160264562 - LIU; Xinchang ; et al.	2016-09-15
Processes For Preparing Dihydropyrimidine Derivatives And Intermediates Thereof App 20160264563 - REN; Qingyun ; et al.	2016-09-15
Processes For Preparing Dihydropyrimidine Derivatives And Intermediates Thereof App 20160244438 - REN; Qingyun ; et al.	2016-08-25
Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof Grant 9,416,139 - Zhang , et al. August 16, 2	2016-08-16
Crystalline forms of dihydropyrimidine derivatives Grant 9,403,814 - Zhang , et al. August 2, 2	2016-08-02
Dihydropyrimidine Compounds And Their Application In Pharmaceuticals App 20160206616 - Zhang; Yingjun ; et al.	2016-07-21
Dihydropyrimidine compounds and their application in pharmaceuticals Grant 9,340,538 - Zhang , et al. May 17, 2	2016-05-17
Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof Grant 9,309,231 - Zhang , et al. April 12, 2	2016-04-12
Spiro compounds as Hepatitis C virus inhibitors Grant 9,303,061 - Zhang , et al. April 5, 2	2016-04-05
Fused Ring Compounds As Hepatitis C Virus Inhibitors, Pharmaceutical Compositions And Uses Thereof App 20150307509 - ZHANG; Yingjun ; et al.	2015-10-29
Spiro Ring Compound As Hepatitis C Virus (hcv) Inhibitor And Uses Thereof App 20150299215 - Zhang; Jiancun ; et al.	2015-10-22
Crystalline Forms Of Dihydropyrimidine Derivatives App 20150239877 - Zhang; Yingjun ; et al.	2015-08-27
Spiro Ring Compounds As Hepatitis C Virus (hcv) Inhibitors App 20150232509 - Zhang; Yingjun ; et al.	2015-08-20
Dihydropyrimidine Compounds And Their Application In Pharmaceuticals App 20150152096 - ZHANG; Yingjun ; et al.	2015-06-04
Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof App 20150079028 - Zhang; Yingjun ; et al.	2015-03-19
Spiro Compounds As Hepatitis C Virus Inhibitors App 20140147412 - Zhang; Jiancun ; et al.	2014-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.